drugset / Trial / NCT02985541
Mirena Extension Trial
NaSingle-groupOpen-labelTreatment
Summary
The study is performed to assess if Mirena is effective and safe as a birth control method beyond 5 years of use. Further the menstrual blood loss (in women that had Mirena inserted for the indication heavy menstrual bleeding \[HMB\]) and safety will be assessed.
Timeline
- Start
- 2016-12-22
- Primary completion
- 2021-05-28
- Completion
- 2021-05-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levonorgestrel | Small molecule | 20 ug | Other |
Indications
No indication recorded.